{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-032664","form_type":"8-K","ticker":"CYCN","cik":"0001755237","company_name":"Cyclerion Therapeutics, Inc.","filed_at":"2023-07-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.120553+00:00","generated_at":"2026-06-13T09:32:29.173265+00:00","sec_items":["8.01"],"event_type":"litigation","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cyclerion discloses lawsuit challenging its asset sale; issues supplemental proxy disclosures","bullets":["One lawsuit and five demand letters allege false/misleading proxy statement for the $8M + 10% stock sale to JW Celtics.","Supplemental disclosures: Stifel contacted 65 potential counterparties, 30 signed NDAs; no 'don't-ask-don't-waive' provisions.","Stifel's fee is $1.3M, mostly contingent on closing; $50k retainer credited. DCF shows Purchased Assets value range ($14M)-$4.4M.","CEO Peter Hecht will become CEO of Buyer Parent post-closing and received employment offer; no compensation talks before APA signing.","Non-risk-adjusted revenue projections for zagociguat and CY3018 added; risk-adjusted forecasts also disclosed for 2023-2045."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-032664","json":"https://secwatch.observer/filing/0000950170-23-032664.json","markdown":"https://secwatch.observer/filing/0000950170-23-032664.md","text":"https://secwatch.observer/filing/0000950170-23-032664.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1755237/000095017023032664/0000950170-23-032664-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1755237/000095017023032664/cycn-20230712.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T09:32:29.173265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}